Literature DB >> 28846473

Methods for ascertaining norovirus disease burdens.

David J Allen1,2, John P Harris3,2.   

Abstract

Norovirus is the commonest cause of gastrointestinal disease worldwide in. Infections with norovirus occur in all age groups, however, the highest incidence is in children aged less than five years. Surveillance of norovirus is complicated because most people do not contact medical services when they are ill. Nevertheless, Public health laboratory surveillance worldwide has demonstrated the dominance of GII.4 viruses in the population. Better epidemiological surveillance and outbreak investigations, coupled with wider implementation of molecular-based laboratory diagnostics are leading to better estimates of the burden of norovirus infections as well as improved outbreak control. Recent advances in cell culture systems for norovirus and current research investigating the distribution of norovirus-associated disease in the population, for whom the disease burden is greatest, understanding host susceptibility factors, and methodologies for ascertaining cases, are important in increasing our understanding of norovirus. The key to surveillance of norovirus is allying the epidemiology with surveillance of virology. With recent advances in laboratory culture systems for norovirus, next generation sequencing technologies, improved diagnostics and measuring phenotypic characteristics of noroviruses, there are new opportunities to advance understanding of this common and important human pathogen that will help design strategies for vaccine and antiviral development, and how these might be best deployed to control norovirus infection.

Entities:  

Keywords:  calicivirus; disease burden; infectious disease; norovirus; transmssion

Mesh:

Year:  2017        PMID: 28846473      PMCID: PMC5703376          DOI: 10.1080/21645515.2017.1360455

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  89 in total

Review 1.  Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2005-06       Impact factor: 17.079

2.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

3.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

4.  Norwalk-like virus infection in military forces: epidemic potential, sporadic disease, and the future direction of prevention and control efforts.

Authors:  M McCarthy; M K Estes; K C Hyams
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

5.  Norovirus Whole-Genome Sequencing by SureSelect Target Enrichment: a Robust and Sensitive Method.

Authors:  Julianne R Brown; Sunando Roy; Christopher Ruis; Erika Yara Romero; Divya Shah; Rachel Williams; Judy Breuer
Journal:  J Clin Microbiol       Date:  2016-08-03       Impact factor: 5.948

6.  Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Authors:  Gabriel I Parra; Karin Bok; Ross Taylor; Joel R Haynes; Stanislav V Sosnovtsev; Charles Richardson; Kim Y Green
Journal:  Vaccine       Date:  2012-03-31       Impact factor: 3.641

7.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

8.  Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

Authors:  Ben Lopman; Harry Vennema; Evelyne Kohli; Pierre Pothier; Alicia Sanchez; Anabel Negredo; Javier Buesa; Eckart Schreier; Mark Reacher; David Brown; Jim Gray; Miren Iturriza; Chris Gallimore; Blenda Bottiger; Kjell-Olof Hedlund; Maria Torvén; Carl-Henrik von Bonsdorff; Leena Maunula; Mateja Poljsak-Prijatelj; Janet Zimsek; Gábor Reuter; György Szücs; Béla Melegh; Lennart Svennson; Yvonne van Duijnhoven; Marion Koopmans
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

9.  Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA.

Authors:  Kazuhiko Katayama; Kosuke Murakami; Tyler M Sharp; Susana Guix; Tomoichiro Oka; Reiko Takai-Todaka; Akira Nakanishi; Sue E Crawford; Robert L Atmar; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205

10.  Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales.

Authors:  Ben Lopman; Ben Armstrong; Christina Atchison; Jim J Gray
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more
  1 in total

1.  Study of Risk Factors for Total Attack Rate and Transmission Dynamics of Norovirus Outbreaks, Jiangsu Province, China, From 2012 to 2018.

Authors:  Jing Ai; Yuanzhao Zhu; Jianguang Fu; Xiaoqing Cheng; Xuefeng Zhang; Hong Ji; Wendong Liu; Jia Rui; Jingwen Xu; Tianlong Yang; Yao Wang; Xingchun Liu; Meng Yang; Shengnan Lin; Xiaohao Guo; Changjun Bao; Qun Li; Tianmu Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.